Picture of Anygen Co logo

196300 Anygen Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Anygen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7,164-6,645-2,462-1,690-6,205
Depreciation
Amortisation
Non-Cash Items3,9242,9464231,3633,695
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-131915-370-1,423-2,982
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-2,033-737-48.3916-2,547
Capital Expenditures-10,030-3,355-959-2,090-2,425
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-8,2953,407-3471,4544,699
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-18,32551.9-1,306-6362,274
Financing Cash Flow Items1,0224006.170
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities16,270-30.31,683-130-481
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-4,086-716322148-759

Or unlock with your email

Or unlock with your email

0